Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 13/20 | 0.47 |
| ▸ | PPARA | Q07869 | 11/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6380944 | 0.91 | LDHA (0.62) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL995776 | 0.87 | LDHA (0.52) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL10970589 | 0.87 | LDHA (0.52) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL4564099 | 0.87 | LDHA (0.52) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL10335497 | 0.87 | LDHA (0.52) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL11360869 | 0.85 | LDHA (0.50) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL9331782 | 0.83 | LDHA (0.48) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL10880781 | 0.83 | KMT2A (0.55) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL20592934 | 0.82 | LDHA (0.47) | LDHACYP1A2GAACYP2C9PKM | |
| SCHEMBL26134046 | 0.82 | LDHA (0.52) | LDHACYP1A2GAACYP2C9PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12447321-B2 | Medicant eluting adjuncts and methods of using medicant eluting adjuncts | CILAG GMBH INTERNATIONAL (CH) | 2025-10-21 | — | — | US | disclosed |
| US-11839733-B2 | Medicant eluting adjuncts and methods of using medicant eluting adjuncts | CILAG GMBH INTERNATIONAL (CH) | 2023-12-12 | — | — | US | disclosed |
| US-11826535-B2 | Medicant eluting adjuncts and methods of using medicant eluting adjuncts | CILAG GMBH INTERNATIONAL (CH) | 2023-11-28 | — | — | US | disclosed |
| EP-3138589-B1 | SURGICAL ADJUNCTS HAVING MEDICANTS CONTROLLABLY RELEASABLE THEREFROM | ETHICON LLC (PR) | 2023-08-09 | — | — | EP | disclosed |
| US-20230078145-A1 | MEDICANT ELUTING ADJUNCTS AND METHODS OF USING MEDICANT ELUTING ADJUNCTS | CILAG GMBH INTERNATIONAL (CH) | 2023-03-16 | — | — | US | disclosed |
| CN-114957065-A | Malonic acid dithioester compound, preparation method and application thereof | 沈阳化工大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-108348659-B | Surgical adjunct having a medicant controllably releasable therefrom | 伊西康有限责任公司 | 2021-09-03 | — | — | CN | disclosed |
| US-20210196936-A1 | MEDICANT ELUTING ADJUNCTS AND METHODS OF USING MEDICANT ELUTING ADJUNCTS | CILAG GMBH INTERNATIONAL (CH) | 2021-07-01 | — | — | US | disclosed |
| US-20200155822-A1 | MEDICANT ELUTING ADJUNCTS AND METHODS OF USING MEDICANT ELUTING ADJUNCTS | ETHICON LLC | 2020-05-21 | — | — | US | disclosed |
| US-10569071-B2 | Medicant eluting adjuncts and methods of using medicant eluting adjuncts | ETHICON LLC (US) | 2020-02-25 | — | — | US | disclosed |
| EP-0729466-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014013-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995014014-A2 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
| EP-0085115-B2 | MODIFIED BLOCK COPOLYMER COMPOSITION | ASAHI CHEMICAL IND (JP) | 1995-04-19 | — | — | EP | disclosed |
| US-5342348-A | Stents having delivery matrices which provide for the controlled release of bioactive substances | KAPLAN AARON V (US) | 1994-08-30 | — | — | US | disclosed |
| WO-1994013268-A1 | METHOD AND DEVICE FOR TREATING AND ENLARGING BODY LUMENS | KAPLAN AARON V (US) | 1994-06-23 | — | — | WO | disclosed |
| EP-0085115-B1 | MODIFIED BLOCK COPOLYMER COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0282052-A2 | Polyphenylene ether resin composition | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-09-14 | — | — | EP | disclosed |
| US-4140520-A | 3,5-Dichloropyridyl-2-oxy-phenoxy malonic acids and derivatives and herbicidal use thereof | ISHIHARA SANGYO KAISHA LTD. (JP) | 1979-02-20 | — | — | US | disclosed |
| US-4140520-A | 3,5-Dichloropyridyl-2-oxy-phenoxy malonic acids and derivatives and herbicidal use thereof | ISHIHARA SANGYO KAISHA LTD. (JP) | 1979-02-20 | — | — | US | disclosed |